Recent Updates
Recently added Catalysts
ELDN Positive Sentiment

Marina Escudero

Key Takeaway: Marina Escudero has been appointed as Vice President and Head of Clinical Operations at Eledon, effective January 2024. With over 20 years of experience in pharmaceutical R&D, she has played a significant role in drug development across various phases. Previously, she held leadership positions at Leap Therapeutics and Kiniksa Pharmaceuticals, and founded Caliber Clinical Consulting.
Price reaction · baseline $1.35 (2023-09-29T16:21:00.000Z) · hit during market hours · 10 other ELDN headline(s) in the window, move may be shared
day 0 close · peak
+1.5%

Market Sentiment Analysis

POSITIVE FACTORS

  • Ms. Escudero brings over 20 years of R&D experience.
  • She has successfully contributed to the registration of multiple pharmaceutical products.
  • Her leadership in clinical operations is expected to enhance Eledon's capabilities.

BiopharmaWatch Analysis

From our catalyst data and publicly available data · not financial advice
Best trade, last catalyst
+90%
120-day peak, hindsight
Typical move
6.5%
average across 7 past catalysts
Cash runway
~11 mo
Medium dilution risk
Lead asset
AT-1501
Phase 2 · Kidney Transplant Rejection

Full Press Release Details

Ms. Escudero has served as Vice President, and Head of Clinical Operations since January 2024. Ms. Escudero has over 20 years of R&D experience in the pharmaceutical industry, where she has been involved in various stages of drug development, from early phase 1 trials to registrational phase 3 studies, which led to the successful registration of multiple small and large molecule pharmaceutical products. Prior to joining Eledon, Ms. Escudero served as VP of Clinical Development Operations at Leap Therapeutics, overseeing all operational facets of the clinical programs. Before Leap Therapeutics, she founded Caliber Clinical Consulting, LLC, providing independent consultation services to biopharmaceutical companies. Prior to Caliber Clinical Consulting, Ms. Escudero served as VP of Clinical Development Operations at Kiniksa Pharmaceuticals, where she managed multiple clinical programs at various stages of development. Ms. Escudero earned her B.S. in Behavior Neuroscience from Northeastern University.

Frequently Asked Questions

What is Marina Escudero's role at Eledon?

Marina Escudero serves as Vice President and Head of Clinical Operations.

How much experience does Ms. Escudero have in R&D?

Ms. Escudero has over 20 years of experience in pharmaceutical R&D.

Where did Ms. Escudero work before Eledon?

She previously worked at Leap Therapeutics and Kiniksa Pharmaceuticals.

What degree does Marina Escudero hold?

She earned a B.S. in Behavior Neuroscience from Northeastern University.

Last updated: Sep 29, 2023